Gabelli Funds’s Anika Therapeutics ANIK Stock Holding History

Gabelli Funds’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,800	Closed	-$563K	–	1360
2021 Q1	$563K	Buy	+13,800	New	+$523K	﹤0.01%	1005
2019 Q3	–	Sell	-6,000	Closed	-$244K	–	1120
2019 Q2	$244K	Sell	6,000 -2,664	-31%	-$97.1K	﹤0.01%	1067
2019 Q1	$262K	Sell	8,664 -3,336	-28%	-$114K	﹤0.01%	1059
2018 Q4	$403K	Hold	12,000	–	–	﹤0.01%	1001
2018 Q3	$506K	Hold	12,000	–	–	﹤0.01%	1009
2018 Q2	$384K	Buy	12,000 +6,000	+100%	+$247K	﹤0.01%	1038
2018 Q1	$298K	Sell	6,000 -1,000	-14%	-$56.5K	﹤0.01%	1069
2017 Q4	$377K	Hold	7,000	–	–	﹤0.01%	1028
2017 Q3	$406K	Hold	7,000	–	–	﹤0.01%	1020
2017 Q2	$345K	Hold	7,000	–	–	﹤0.01%	1049
2017 Q1	$304K	Hold	7,000	–	–	﹤0.01%	1053
2016 Q4	$343K	Hold	7,000	–	–	﹤0.01%	1055
2016 Q3	$335K	Hold	7,000	–	–	﹤0.01%	1070
2016 Q2	$376K	Hold	7,000	–	–	﹤0.01%	1062
2016 Q1	$313K	Hold	7,000	–	–	﹤0.01%	1056
2015 Q4	$267K	Hold	7,000	–	–	﹤0.01%	1065
2015 Q3	$223K	Hold	7,000	–	–	﹤0.01%	1034
2015 Q2	$231K	Hold	7,000	–	–	﹤0.01%	1039
2015 Q1	$288K	Hold	7,000	–	–	﹤0.01%	1018
2014 Q4	$285K	Sell	7,000 -500	-7%	-$19.5K	﹤0.01%	1033
2014 Q3	$275K	Hold	7,500	–	–	﹤0.01%	1041
2014 Q2	$347K	Hold	7,500	–	–	﹤0.01%	1003
2014 Q1	$308K	Sell	7,500 -500	-6%	-$18.6K	﹤0.01%	1002
2013 Q4	$305K	Buy	+8,000	New	+$247K	﹤0.01%	993

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gabelli Funds's ANIK Position: Q2 2021 in Review

Gabelli Funds sold out of Anika Therapeutics (ANIK) in Q2 2021, closing a stake of 13,800 shares — an estimated $563K sold.

Gabelli Funds first reported a position in ANIK in Q4 2013 and held it in 24 quarters. The position peaked at $563K in Q1 2021. 139 funds tracked by Wall St. Rank hold ANIK as of Q2 2021.

Gabelli Funds reported no remaining Anika Therapeutics position as of Q2 2021 after selling out during the quarter.
Gabelli Funds sold 13,800 Anika Therapeutics shares in Q2 2021, an estimated $563K.
Gabelli Funds first reported a position in Anika Therapeutics in Q4 2013 and held it in 24 quarters.
Gabelli Funds's Anika Therapeutics position peaked at $563K in Q1 2021.
139 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2021.

Based on Gabelli Funds's 13F filing for Q2 2021, filed 13 Aug 2021.